- Home
- / Synergy Pharmaceuticals
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Synergy Pharmaceuticals financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Total Funding
$407.2 M
Revenue
$16.8 M
FY, 2017
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 |
|---|---|---|---|---|---|---|---|
| Revenue | 16.8M | ||||||
| Cost of goods sold | 8.8M | ||||||
| Gross profit | 8.0M | ||||||
| Gross profit margin, % | 47.6% | ||||||
| General and administrative expense | 6.7M | 7.9M | 11.7M | 11.0M | 21.8M | 55.7M | 181.9M |
| Operating expense total | 20.2M | 37.2M | 62.3M | 94.3M | 99.8M | 145.3M | 230.2M |
| EBIT | (20.2M) | (38.2M) | (62.3M) | (94.3M) | (99.8M) | (145.3M) | (222.2M) |
| EBIT margin, % | -1321.0% | ||||||
| Investment income | 89.7K | 218.0K | 59.0K | (2.5M) | |||
| Interest income | 362.5K | 506.0K | 83.0K | 121.0K | |||
| Interest expense | 11.9K | 1.2M | 187.0K | 2.5M | 17.7M | 53.3M | 2.1M |
| Net Income | (14.5M) | (39.4M) | (62.1M) | (95.7M) | (117.5M) | (198.6M) | (224.3M) |